Hamburger

Manumangalanubhai Manumangalangaldas Securities Pvt. Ltd. Member: BSE - NSE - CDSL

Technology . Transparency . Trust

MARKET

IPO Synopsis
Asston Pharmaceuticals Ltd
Registered Office: 4th Flr Office No.A-431 Balaji, Bhavan Plot No.42A Sec-11 CBD, Mumbai - 400614, Maharashtra
Phone: 1
Email: 1
Website: 1
Initial public issue of up to 22,41,000 equity shares of face value of Rs.10/- each (the "Equity Shares") of Asston Pharmaceuticals Limited ("the Company" or "APL" or "the Issuer") at an issue price of Rs. 123 per equity share for cash, aggregating up to Rs. 27.56 crores ("Public Isue") out of which upto 1,13,000 equity shares of face value of Rs. 10/- each, at an issue price of Rs. 123 per equity share for cash, aggregating Rs. 1.39 crores will be reserved for subscription by the market maker to the issue (the "Market Maker Reservation Portion"). The public issue less market maker reservation portion i.e. issue of upto 21,28,000 equity shares of face value of Rs. 10/- each, at an issue price of Rs. 123 per equity share for cash, aggregating upto Rs. 26.17 crores is herein after referred to as the "Net Issue". The public issue and net issue will constitute 26.33 % and 25 %, respectively of the post-issue paid-up equity share capital of the company.
Issue Money Payable On
Opens On Closes On Application Allotment
09-Jul-2025 11-Jul-2025 123.00 - 0.00 0.00 - 0.00
Cr. Lead Managers to the Issue
Project Cost 23.95
Project Financed through Current Offer 27.56
Post Issue Equity Share Capital 8.51
Issue Price 123.00
Projects
Funding capital expenditure requirements towards acquiring machinery in the manufacturing unit
Funding the incremental working capital requirements of our company
Repayment and/or prepayment, in part or full, of certain of our outstanding borrowings availed by our company.
General corporate purposes
Promoted By
Ashish Narayan Sakalkar
Saili Jayaram More
Sachin Chandrakant Badakh
BSE - SME
Registrar to the Issue
Maashitla Securities Pvt Ltd
Attention Investor
As per CDSL communiqué, kindly update your Email ID, Mobile Number and Income Range in your CDSL Demat Account on or before 31st May 2021. Non-compliant accounts will become inactive after 31st May 2021.  |  Prevent unauthorized transactions in your Demat account by updating your registered mobile number with your Depository Participant. Receive alerts for all debit and other important transactions directly from CDSL.  |  No need to issue cheques while subscribing to an IPO. Simply authorize your bank account in the application form.  |  KYC is a one-time process. Once completed through a SEBI-registered intermediary, you do not need to repeat it with another intermediary.  |  Update your mobile number and email ID with your stock broker to receive transaction alerts directly from the Exchange.